Healthcare Facilities company GPT Healthcare announced Q1FY27 results Financial Highlights: Revenue from operations of Rs 12,620.43 lakh for Q1FY27, reflecting a YoY growth of 17.83% compared to Rs 10,710.86 lakh in Q1FY26 and a slight QoQ decrease of 0.13% from Rs 12,637.18 lakh in Q4FY26. Total Income for the quarter stood at Rs 12,823.04 lakh in Q1FY27, representing a YoY increase of 18.00% from Rs 10,867.16 lakh in Q1FY26 and a marginal QoQ increase of 0.18% over Rs 12,800.02 lakh in Q4FY26. Profit before tax reached Rs 1,716.47 lakh in Q1FY27, marking a YoY surge of 54.45% compared to Rs 1,111.36 lakh in Q1FY26 and a QoQ growth of 8.19% from Rs 1,586.48 lakh in Q4FY26. The Net Profit for the quarter was recorded at Rs 1,273.14 lakh in Q1FY27, showing a YoY growth of 65.73% over Rs 768.18 lakh in Q1FY26, while witnessing a QoQ decline of 12.60% from Rs 1,456.60 lakh in Q4FY26. Total Comprehensive Income for the period stood at Rs 1,271.88 lakh in Q1FY27, a YoY growth of 65.83% from Rs 766.99 lakh in Q1FY26 and a QoQ decrease of 12.12% from Rs 1,447.23 lakh in Q4FY26. Earnings Per Share (EPS) for Q1FY27 was Rs 1.55 (Basic and Diluted), compared to Rs 0.94 in Q1FY26 and Rs 1.78 in Q4FY26. Business Highlights: Corporate Structure: As of Q1FY27, the company does not have any subsidiary, associate, or joint venture companies; therefore, it is not required to prepare consolidated financial results. Audit Review: The financial results for Q1FY27 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 3, 2026. The statutory auditors issued an unmodified conclusion on these results. Accounting Standards: The results have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. Result PDF
GPT Healthcare company GPT Healthcare announced Q4FY26 & FY26 results Financial Highlights: Total Income: Total Income for Q4FY26 stood at Rs 12,800.02 lakh, reflecting a QoQ increase of 5.28% compared to Rs 12,158.02 lakh in Q3FY26, and a robust YoY growth of 24.30% from Rs 10,297.51 lakh in Q4FY25. For FY26, the Total Income was Rs 47,849.82 lakh, marking a YoY increase of 15.14% compared to Rs 41,558.57 lakh in FY25. Revenue from Operations: Revenue from operations in Q4FY26 reached Rs 12,637.18 lakh, up 5.17% QoQ from Rs 12,015.86 lakh in Q3FY26, and up 24.62% YoY from Rs 10,140.22 lakh in Q4FY25. For FY26, it was Rs 47,254.70 lakh against Rs 40,709.14 lakh in FY25 (a YoY increase of 16.08%). Profit Before Tax (PBT): PBT for Q4FY26 stood at Rs 1,586.48 lakh, demonstrating a QoQ growth of 24.35% from Rs 1,275.77 lakh in Q3FY26, but a marginal YoY decline of 3.08% from Rs 1,636.89 lakh in Q4FY25. For FY26, PBT was Rs 5,480.55 lakh, declining by 20.97% YoY compared to Rs 6,934.56 lakh in FY25. Net Profit After Tax (PAT): In Q4FY26, PAT was Rs 1,456.60 lakh, reflecting a significant QoQ growth of 55.48% from Rs 936.83 lakh in Q3FY26, and an increase of 13.00% YoY from Rs 1,289.00 lakh in Q4FY25. For the full year FY26, PAT stood at Rs 4,222.05 lakh, down 15.43% YoY compared to Rs 4,992.17 lakh in FY25. Business Highlights: Segment-wise Performance: The company operates in one single reportable business segment and geographical segment, i.e., healthcare service in India. Dividend Announcement: The Board of Directors proposed a final dividend of 15%, i.e., Rs 1.50 per Equity share. With an interim dividend of 10% (Rs 1 per Equity share) already paid, the total dividend for FY26 amounts to Rs 2.50 per Equity share (face value of Rs 10 per share). Labour Codes Impact: Following the notification of the 'New Labour Codes' by the Government of India, the company undertook an actuarial valuation for the year ended March 31, 2026, and recorded an incremental expense as a past service cost. The impact was deemed not material to the financial results. Om Tantia, GPT Healthcare Chairman, said: GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities. Network occupancy improved during the quarter, supported by higher patient volumes, enhanced throughput, and a stronger specialty mix, while ARPOB recorded year-on-year growth, with ARPOB for FY26 at Rs 39,243, aligned with our strategy of serving the aspirational middle- to high-income population while maintaining affordability. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience. We continued to strengthen our clinical and technological leadership, completing over 800+ robotic surgeries at ILS Salt Lake, reinforcing our position in advanced minimally invasive care, and commissioning the CTVS (Cardiothoracic and Vascular Surgery) in ILS-Dum Dum, ensuring complete cardiac care being provided under one roof. Result PDF
Conference Call with GPT Healthcare Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company GPT Healthcare announced Q3FY26 results Revenue: Rs 121.6 crore against Rs 104.1 crore during Q3FY25, change 17%. EBITDA: Rs 22.2 crore against Rs 23.1 crore during Q3FY25, change -4%. EBITDA Margin: 18.2% for Q3FY26. PAT: Rs 9.4 crore against Rs 12.1 crore during Q3FY25, change -22%. PAT Margin: 7.71% for Q3FY26. Om Tantia, Chairman, GPT Healthcare, said: GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities. Network occupancy improved during the quarter, supported by higher patient volumes, enhanced throughput, and a stronger specialty mix, while ARPOB recorded YoY growth, with ARPOB for 9M’FY26 at Rs 38,797, aligned with our strategy of serving the aspirational middle- to high-income population while maintaining affordability. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience. We continued to strengthen our clinical and technological leadership, completing over 750+ robotic surgeries at ILS Salt Lake, reinforcing our position in advanced minimally invasive care, and commissioning the CTVS (Cardiothoracic and Vascular Surgery) in ILS-Dum Dum, ensuring complete cardiac care being provided under one roof. Result PDF
Healthcare Facilities company GPT Healthcare announced Q2FY26 results Q2FY26, the revenue from operations grew by 12.5% to Rs 118.9 crore. EBITDA stood at Rs 24.1 crore in Q2FY26 with a margin of 20% Om Tantia, GPT Healthcare, Chairman, said: “The quarter gone by was a deep personal loss to me and the entire team at GPT. Our beloved Chairman and my brother, Shri Dwarika Prasad Tantia left for his heavenly abode on August 17, 2025. He showed us that greatness lies in humility and that integrity is the finest legacy. A true leader who lived each day with strong sense of family values and his legacy in business and community service is profound. Through his vision and actions, he left our world richer, wiser, and better than he found it. We thank each one who reached out to us to offer their condolences in this time of grief. We have always focused on strong operational and financial parameters, and this is reflective in our results for the quarter despite the changing case mix across all hospitals. The ARPOB for H1FY26 was Rs 38,376 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. Furthermore, we completed 700+ robotic surgeries at ILSS and commenced renal transplant and oncology services at ILSR.” Result PDF
Healthcare Facilities company GPT Healthcare announced Q1FY26 results Revenue from Operations stood at Rs 107.1 crore, higher by 9.5% YoY. EBITDA stood at Rs 18.9 crore, with EBITDA margin of 17.4%. PAT stood at Rs 7.7 crore, PAT margin of 7.1% Dwarika Prasad Tantia, GPT Healthcare Chairman, said: “We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the changing case mix across all hospitals. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and reducing ALOS. The ARPOB for Q4FY25 was Rs 38,913 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. We are committed to becoming a 1,000-bed hospital chain within the next 2–3 years. As part of this vision, we commissioned a 158-bed multi-specialty hospital at Pachpedi Naka, Raipur on 2nd May 2025, under an asset-light, rental-based model with a Rs 55 crore investment. Serving Raipur and nearby districts including Bilaspur, Durg, and Bhilai, the facility offers advanced care across Cardiac Sciences, Oncology, Neurology, Orthopaedics, Paediatrics, and more. It is equipped with state-of-the-art technology including a 3 Tesla MRI, 128-slice Dual Source CT, Cardiac Cath Lab, and 5 modular OTs. Designed for quaternary care and complex treatments, the hospital is backed by a highly skilled team & has been fully commissioned. Additionally, we have signed an MoU for a hospital in Jamshedpur, with a planned capacity of 150 beds and an estimated cost of approximately Rs 74 Cr. The hospital is expected to be commissioned by the end of FY27. Furthermore, we commenced robotic knee surgeries at our Howrah hospital and performed 12 such procedures in Q4FY25. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF
Healthcare Facilities company GPT Healthcare announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: During the Q4FY25, the total income stood at Rs 103.0 crore with EBITDA at Rs 22.2 crore. The Net profit stood at Rs 12.8 crore in Q4FY25 with PAT margin of 12.4% FY25 Financial Highlights: Total Income stood at 415.6 crore, higher by 2.5% y-o-y EBITDA stood at Rs 91.9 crore, with EBITDA margin of 22.1% PAT stood at Rs 50.0 crore, PAT margin of 12.0% The Total Dividend declared for FY 2024-25 of Rs 2.5 per share, including final dividend of Rs 1.5 per share Commenting on the performance, GPT Healthcare Chairman, Dwarika Prasad Tantia, said, “We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the changing case mix across all hospitals. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and reducing ALOS. The ARPOB for Q4FY25 was Rs 37,180 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. We are committed to becoming a 1,000-bed hospital chain within the next 2–3 years. As part of this vision, we commissioned a 158-bed multi-specialty hospital at Pachpedi Naka, Raipur on 2nd May 2025, under an asset-light, rental-based model with a Rs 55 crore investment. Serving Raipur and nearby districts including Bilaspur, Durg, and Bhilai, the facility offers advanced care across Cardiac Sciences, Oncology, Neurology, Orthopaedics, Paediatrics, and more. It is equipped with state-of-the-art technology including a 3 Tesla MRI, 128-slice Dual Source CT, Cardiac Cath Lab, and 5 modular OTs. Designed for quaternary care and complex treatments, the hospital is backed by a highly skilled team & has been fully commissioned. Additionally, we have signed an MoU for a hospital in Jamshedpur, with a planned capacity of 150 beds and an estimated cost of approximately Rs 74 Cr. The hospital is expected to be commissioned by the end of FY27. Furthermore, we commenced robotic knee surgeries at our Howrah hospital and performed 12 such procedures in Q4FY25. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, high quality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF
Healthcare Facilities company GPT Healthcare announced Q3FY25 results Revenue from Operations stood at 102.2 crore. EBITDA stood at Rs 23.1 crore, with EBITDA margin of 22.2%. PAT stood at Rs 12.2 crore, PAT margin of 11.7%. Dwarika Prasad Tantia, GPT Healthcare Chairman, said: “We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the changing case mix across all hospitals. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and reducing ALOS. The ARPOB for Q3FY25 was Rs 36,700 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. We are determined to become a 1,000-bed hospital chain within the next 2-3 years. Our upcoming hospital in Raipur is on track and commissioning expected in March or early April, is a Rs 55 crore investment with an asset-light, rentalbased model. The 152-bed facility includes ICUs, HDUs, OTs, and specializes in oncology facilities. Equipped with cutting-edge technology like a 3 Tesla MRI and Dual Source CT Scan, it’s designed for quaternary care and complex treatments, supported by a highly skilled team. Additionally, we have signed an MoU for our third hospital in Jamshedpur, which will have a capacity of 150 beds and an estimated cost of approximately Rs 65 crore. Furthermore, we have commenced robotic knee surgeries at our Howrah hospital. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF
Healthcare Facilities company GPT Healthcare announced Q2FY25 results Revenue from Operations stood at 105.7 crore. EBITDA stood at Rs 26.3 crore, with EBITDA margin of 24.2%. PAT stood at Rs 14.8 crore, PAT margin of 13.7% Dwarika Prasad Tantia, Chairman, GPT Healthcare, said: “We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the changing case mix across all hospitals. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and reducing ALOS. The ARPOB for Q2FY25 was Rs 36,700 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. We are steadfast to become a 1,000 bed hospital chain in the next 2-3 years. Our upcoming hospital in Raipur is on track and is expected to be commissioned in Q4FY25 and the radiation oncology has been commissioned in November this year for the Agartala Hospital. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF
Healtcare Facilities company GPT Healthcare announced Q1FY25 results: Total Income stood at Rs 100.1 crore, higher by 2.5% YoY EBITDA stood at Rs 20.2 crore, with EBITDA margin of 20.2% PAT stood at Rs.10 crore, higher by 10.0% YoY Commenting on the performance, GPT Healthcare Chairman, Dwarika Prasad Tantia, said, “We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the overhang due to the general elections. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and increasing occupancy. The ARPOB for Q1FY25 was Rs 36,111 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. Our upcoming hospital in Raipur is on track and is expected to be commissioned in Q4 FY 25 and the radiation oncology to be commissioned in Agartala hospital in CY24. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF